New Drug Might Reduce an Alzheimer’s Marker: Study(?)
MONDAY, April 2 (HealthDay News) — An experimental drug might lower a marker of Alzheimer’s disease seen in the spinal fluid of patients with mild to moderate disease, a small new study finds.
Is this Science, bunk, or even worse, politics? Why is there a press release without helpful findings from this study. And why am I even sharing it? To illustrate part of the problem with translational research, hell, with much of academic science today. So much is hyped without proper merit in the game of grant sequestration.
See all posts on Cognitive Science